EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation

Michelle Mendiola Pla iD, Dawn E Bowles

Human Gene Therapy · 2024-04 · 35 (7-8) · 284-297

DOI: 10.1089/hum.2023.193 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Gene Therapy, online erschienen am 16.04.2024. Verfasst von Michelle Mendiola Pla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Organ Transplantation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ex vivo machine perfusion (EVMP) is rapidly growing in utility during solid organ transplantation. This form of organ preservation is transforming how organs are allocated and expanding the definition of what is considered a suitable organ for transplantation in comparison with traditional static cold storage. All major organs (heart, lung, liver, kidney) have been influenced by this advanced method of organ preservation. This technology also serves as an unprecedented platform for effective administration of advanced therapeutics, including gene therapies, during organ transplantation to optimize and recondition organs ex vivo in an isolated manner. Applying gene therapy interventions through EVMP introduces different considerations and challenges that are unique from gene therapies designed for systemic administration. Considerations involving vector (choice, dose, toxicity), perfusate composition, and perfusion circuit components should be evaluated when developing a gene therapy to administer in this setting. This review explores these aspects and discusses clinical applications in transplantation where gene therapy interventions can be developed relevant to heart, lung, liver, and kidney donor grafts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organ TransplantationOrgan PreservationPerfusionHeartGenetic Therapy

Stichwörter der Autor:innen

gene therapymachine perfusionorgan transplantation

Autor:innen und Institutionen

  • Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.

ORCID-Profile: Michelle Mendiola Pla

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Mendiola Pla, M., & Bowles, D. E. (2024). Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation. Human Gene Therapy, 35(7-8), 284-297. https://doi.org/10.1089/hum.2023.193

Vancouver

Mendiola Pla M, Bowles DE. Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation. Human Gene Therapy. 2024;35(7-8):284-297. doi:10.1089/hum.2023.193

BibTeX
@article{MendiolaPla2024,
  author = {Mendiola Pla, Michelle and Bowles, Dawn E},
  title = {Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation},
  journal = {Human Gene Therapy},
  year = {2024},
  volume = {35},
  number = {7-8},
  pages = {284--297},
  doi = {10.1089/hum.2023.193}
}
Kostenlos starten →